$269.00
In Stock
The Zostavax vaccine is used to prevent herpes zoster (shingles) and postherpetic neuralgia in patients over 50 years of age.
Recent studies have shown that Zostavax significantly reduces the incidence of new cases of shingles compared to placebo. The protective effectiveness of Zostavax against herpes zoster averaged 51%. When the vaccine was prescribed, there was a significant reduction in the incidence of herpes zoster in patients aged 60-69 years by 64% and in patients over 70 years old by 38%.
Store at a temperature of 2 to 8 degrees
Prescription medicine.
